Osprey Medical Inc. | Mutual Funds
Mutual Funds that own Osprey Medical Inc.
Fidelity Funds SICAV - Asian Smaller Companies Fund
8,031,165
2.37%
-236,665
0.15%
05/31/2018
Fidelity Asian Values Plc
4,379,605
1.29%
0
0.18%
05/31/2018
Nikko Global Umbrella Fund - AM Asia-Pacific (ex-Japan)
1,971,048
0.57%
1,971,048
0.47%
12/31/2017
Fidelity Funds SICAV - International Fund
149,976
0.04%
4,130
0%
03/31/2018
Fidelity Funds SICAV - Multi Asset Strategic Fund
66,051
0.02%
775
0%
03/31/2018
Fidelity Funds SICAV - Multi Asset Strategic Defensive Fund
31,678
0.01%
-93
0%
03/31/2018
Fidelity Funds SICAV - Target 2040 (EUR) Fund
4,892
0%
321
0%
03/31/2018
Fidelity Funds SICAV - Target 2030 (EUR) Fund
4,451
0%
293
0%
03/31/2018
4,189
0%
145
0%
03/31/2018
3,864
0%
128
0%
03/31/2018
| Address |
5600 Rowland Road
Minnetonka Minnesota 55343
United States
|
|
Employees
|
- |
| Website |
http://www.ospreymed.com |
| Updated |
09/14/2018 |
| Osprey Medical, Inc. engages in the development, and commercialization of its proprietary products for the prevention of harmful effect of X-ray dye used during commonly performed angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN. |
